Cargando…

SARS-CoV-2 vaccination for patients with inflammatory bowel disease

Detalles Bibliográficos
Autores principales:	Garrido, Hannah M Garcia, Grobusch, Martin P, D'Haens, Geert R A M, Goorhuis, Abraham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192095/ https://www.ncbi.nlm.nih.gov/pubmed/34119034 http://dx.doi.org/10.1016/S2468-1253(21)00148-5

Ejemplares similares

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021)

Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022)

Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine
por: Grobusch, Martin P., et al.
Publicado: (2021)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021)

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy
por: Selim, Rania, et al.
Publicado: (2022)

Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste
por: Gower-Rousseau, Corinne, et al.
Publicado: (2021)

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
por: Wieske, Luuk, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

2939. Hepatitis A vaccine immunogenicity in an immunocompromised population: a prospective cohort study
por: Schnyder, Jenny, et al.
Publicado: (2023)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Hemolytic anemia after switching from infliximab originator to biosimilar CT‐P13 in a patient with inflammatory bowel disease: A case report
por: Strik, Anne S., et al.
Publicado: (2019)

Letter to the Editor on “Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic”
por: Dai, Cong, et al.
Publicado: (2021)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

A strategy for SARS-CoV-2 vaccination in Yemen
por: Nasser, Abdullah, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
por: McCrindle, Brian W., et al.
Publicado: (2023)

Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial
por: Garcia Garrido, Hannah M, et al.
Publicado: (2022)

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
por: Brain, Oliver, et al.
Publicado: (2021)

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
por: Prentice, Ralley E., et al.
Publicado: (2020)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
por: Cirillo, Nicola, et al.
Publicado: (2021)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Ko, Humphrey H T
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Franco-Paredes, Carlos
Publicado: (2022)

Tolerability and impact of SARS-CoV-2 vaccination in elite athletes
por: Hull, James H, et al.
Publicado: (2022)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
por: Harris, Ross J., et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
por: Morimoto, Hiroki, et al.
Publicado: (2022)

Transmission electron microscopy imaging of SARS-CoV-2
por: Prasad, Sharda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n65unfoajm0f2mt6nnif93fmjj